George P. Paraskevas

Author

Also Known As

Adela Orellana, E Anagnostou, G Paraskevas, G. P. Paraskevas, G. Paraskevas, G.P. Paraskevas, George P Paraskevas, George P. Paraskevas, George P.Paraskevas, George Paraskevas

230

Publications

6.6K

Citations

H-Index

118

Concepts

All Affiliations

Eginition Hospital National and Kapodistrian University of Athens Academy of Athens Biomedical Research Foundation of the Academy of Athens University General Hospital Attikon

About

George P. Paraskevas is an author at Eginition Hospital specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	36	1.2K
2	Social Sciences	9	9	494
3	Health Sciences	7	7	156
4	Natural Sciences	1	1	16
5	Anatomy	1	1	18

George P. Paraskevas

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers Niklas Mattsson, Ulf Andréasson, Staffan Persson, Alzheimer s & Dementia	2011	406
Cerebrospinal fluid tau, phospho‐tau<sub>181</sub> and <i>β</i>‐amyloid<sub>1−42</sub> in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease E. Kapaki, George P. Paraskevas, Nikolaos G. Tzerakis, European Journal of Neurology	2007	137
Circulating interleukin-15 and RANTES chemokine in Parkinson’s disease Michael Rentzos, Christoforos Nikolaou, Elisabeth Andreadou, Acta Neurologica Scandinavica	2007	119
Neurofilament ELISA validation Axel Petzold, Ayşe Altıntaş, Laura Andreoni, Journal of Immunological Methods Neuroimaging BiomarkersNeurophysiologyNeurophysiological BiomarkersBiomarkersNeurofilament Elisa Validation	2009	103
Circulating interleukin-10 and interleukin-12 in Parkinson’s disease Michael Rentzos, Christoforos Nikolaou, Elisabeth Andreadou, Acta Neurologica Scandinavica	2009	98
The Stroop Effect in Greek Healthy Population: Normative Data for the Stroop Neuropsychological Screening Test Ioannis Zalonis, Foteini Christidi, Anastasios Bonakis, Archives of Clinical Neuropsychology NeuropsychologyBrain FunctionStroop TestSelective AttentionNeuropsychiatry	2009	87
Increased Cerebrospinal Fluid Tau Protein in Multiple Sclerosis Elisabeth Kapaki, George P. Paraskevas, Maria Michalopoulou, European Neurology	2000	81
CSF biomarkers β-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes Vasilios C. Constantinides, George P. Paraskevas, Evangelia Emmanouilidou, Journal of the Neurological Sciences Neurodegenerative DiseasesTau ProteinsCsf BiomarkersProteinopathiesBiomarkers	2017	81
The Diagnostic Value of CSF α-Synuclein in the Differential Diagnosis of Dementia with Lewy Bodies vs. Normal Subjects and Patients with Alzheimer’s Disease Elisabeth Kapaki, George P. Paraskevas, Evangelia Emmanouilidou, PLoS ONE Csf α-Syn LevelsDiagnostic ValueNeurochemical BiomarkersSynaptic SignalingSocial Sciences	2013	79
CSF tau protein and<i>β</i>‐amyloid (1–42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek population E. Kapaki, George P. Paraskevas, Ioannis Zalonis, European Journal of Neurology	2003	76

Page 1